Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1753-6561
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors ; volume:7 ; number:2 ; day:4 ; month:4 ; year:2013 ; pages:1 ; date:4.2013
BMC proceedings / Biomed Central; 7, Heft 2 (4.4.2013), 1, 4.2013
- Creator
-
Mello, Barbara P.
de Carvalho, Daniel D.
Campos, Antonio HJFM
Soares, Fernando A.
Amarante-Mendes, Gustavo P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1753-6561-7-S2-P10
- URN
-
urn:nbn:de:101:1-2021082909390845538279
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mello, Barbara P.
- de Carvalho, Daniel D.
- Campos, Antonio HJFM
- Soares, Fernando A.
- Amarante-Mendes, Gustavo P.
- SpringerLink (Online service)
Other Objects (12)
EZH2: novel therapeutic target for human cancer
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
EZH2: a novel target for cancer treatment
Integrins regulate stemness in solid tumor: an emerging therapeutic target
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
The potential of PARP as a therapeutic target across pediatric solid malignancies
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Symmetric solid target transport system
A honeycomb solid target design
EZH2: novel therapeutic target for human cancer
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
EZH2: a novel target for cancer treatment
Integrins regulate stemness in solid tumor: an emerging therapeutic target
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
The potential of PARP as a therapeutic target across pediatric solid malignancies
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Symmetric solid target transport system
A honeycomb solid target design
EZH2: novel therapeutic target for human cancer
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
EZH2: a novel target for cancer treatment
Integrins regulate stemness in solid tumor: an emerging therapeutic target
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
The potential of PARP as a therapeutic target across pediatric solid malignancies
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Symmetric solid target transport system